Journal: bioRxiv
Article Title: AUTS2, a causative gene for microcephaly, regulates division of intermediate progenitor cells and production of upper-layer neurons
doi: 10.1101/2024.04.15.589462
Figure Lengend Snippet: (A) Targeting strategy of CRISPR/Cas9 method for the generation of Eomes T2A-d2EGFP knock-in mouse. The DNA sequences for T2A-d2EGFP were inserted between the last amino acid and the stop codon of the Eomes locus. L-HA, left homology arm; R-HA, right homology arm; ssDNA, single-stranded donor DNA; F, forward primer for genotyping; R1 and R2, reverse primers for genotyping. (B) In vitro digestion assay to check the cleavage activity of the crRNA designed in (A). Targeted PCR products of the Eomes locus were cleaved in the presence of the chemically synthesized guide RNA ( Eomes crRNA/tracrRNA) combined with Cas9 protein. M, molecular marker. (C) Genotyping for WT and Eomes T2A-d2EGFP/+ (KI) mouse using primers indicated in (A). (D) Western blotting analysis of cerebral cortical lysates in WT, Eomes T2A-d2EGFP/+ (KI/+), and Eomes T2A-d2EGFP/T2A-d2EGFP (KI/KI) mice at E14.5 with anti-TBR2 and anti-ß-actin antibodies. A very small amount of uncleaved TBR2-T2A-d2EGFP protein was observed at the long exposure (arrow); however, most signals for TBR2 were detected around the expected size for TBR2 protein (short exposure), indicating that TBR2 and d2EGFP proteins were efficiently cleaved in those mice. (E) Whole-mount images in WT and Eomes T2A-d2EGFP/T2A-d2EGFP (KI/KI) mouse brains at E18.5. Scale bars, 1 mm. (F) Representative images of staining with DAPI (blue), anti-GFP (green), and anti-TBR2 (magenta) antibodies in Eomes T2A-d2EGFP/+ cortical sections at E14.5. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bars, 50 µm. (G) RT-qPCR analysis for Sox2, Nes, Pax6, Eomes, Neurod1 and Tbr1 in the cerebral cortex, sorted CD133 high cells and sorted EGFP + cells from Eomes T2A-d2EGFP/+ mice at E15.5. Data are presented as mean ± SD (N = four biological replicates); One-way ANOVA with Turkey’s post-hoc test or Kruskal–Wallis test.
Article Snippet: The following primary antibodies were used, rabbit anti-CUX1 (1:1000; sc-13024; Santa Cruz Biotechnology, Danvers, MA), rat anti-CTIP2 (1:3000; ab18465; abcam), rabbit anti-cleaved caspase-3 (1:400; 9661S; Cell Signaling Technology, Danvers, MA), rabbit anti-PAX6 (1:500; 901301; BioLegend, San Diego, CA), rabbit anti-TBR2 (1:1000; ab183991; abcam), rat anti-TBR2 (1:500; 14-4876-80; Invitrogen, Carlsbad, CA), rat anti-PH3 (pSer28) (1:400; H9908; Sigma-Aldrich, St. Louis, MO), rat anti-KI67 (1:500; 14-5698-82; Invitrogen), sheep anti-BrdU (1:200; ab1893; abcam), chicken anti-GFP (1:1000; ab13970; abcam), and goat anti-SOX2 (1:200; AF2018; R&D systems, Minneapolis, MN).
Techniques: CRISPR, Knock-In, In Vitro, Activity Assay, Synthesized, Marker, Western Blot, Staining, Quantitative RT-PCR